Posts Tagged ‘ Alzheimers ’

Signs And Symptoms Of Alzheimer’s Disease

January 21, 2011
By

One of the most common causes for dementia is Alzheimer’s disease. Alzheimer’s disease is the loss of intellectual and social abilities severe enough to interfere with daily functioning. The dementia is caused when healthy brain tissue degenerates. Memory and mental abilities steadily decline.

Alzheimer’s disease usually develops in people 65 or older. There is no cure for Alzheimer’s disease; however, researches are making progress. There are treatments available to improve the quality of life for some people with Alzheimer’s disease.

Signs and symptoms of Alzheimer’s disease include:

• Increasing and persistent forgetfulness: In the beginning of Alzheimer’s disease a person may experience periods of forgetfulness, especially of recent events or simple directions. This forgetfulness persists and worsens. People with Alzheimer’s disease routinely misplace things, often putting them in strange or “illogical” places. They frequently forget names, and may even eventually forget the names of family members and everyday objects.

• Difficulties with abstract thinking: People who suffer with Alzheimer’s disease may initially have trouble balancing their checkbook and may progress to trouble recognizing numbers.

• Loss of judgment: Common everyday problem solving such as knowing what to do if food on the stove is burning becomes increasingly difficult, eventually impossible. There is greater difficulty in doing things that require planning, decision making and judgment.

• Difficulty performing familiar tasks: Routine tasks that require sequential steps such as cooking become increasingly difficult as the disease progresses.

• Personality changes: Mood swings may occur. People with Alzheimer’s disease may begin to distrust others, become anxious or aggressive, show stubbornness and withdraw socially.

It is not a normal part of aging to forget the names of familiar people and objects, and may be a sign of Alzheimer’s disease. It is normal to forget the names of people whom you rarely see, but to forget the names of familiar people you see everyday is not normal.

Alzheimer’s disease is a progressive, degenerative brain disease that causes more than simple forgetfulness every now and then. Eventually, Alzheimer’s disease leads to irreversible mental impairment that destroys a person’s ability to remember, reason, learn and imagine.

The disease progresses differently from person to person. Once diagnosed with Alzheimer’s disease, eight years is the average length of time unto death. Some people, however, live more than a decade with the disease. Survival begins to decline three years after diagnosis.

Source: Mayo Foundation for Medical Education and Research

Disclaimer: *This article is not meant to diagnose, treat or cure any kind of a health problem. These statements have not been evaluated by the Food and Drug Administration. Always consult with your health care provider about any kind of a health problem and especially before beginning any kind of an exercise routine.

This article is FREE to publish with the resource box. Article written 3-2007.

Connie Limon, Trilogy Field Representative. Visit http://nutritionandhealthhub.com and sign up for a weekly nutrition and health tip. The article collection is available as FREE reprints for your newsletters, websites or blog. Visit http://www.healthylife27.com to purchase an array of superior quality, safe and effective products inspired by nature, informed by science and created to improve the health of people, pets and the planet.

Treating Alzheimer’s Disease

January 12, 2011
By

Treating Alzheimer’s Disease

Health Articles | July 17, 2007

Age is the most important risk factor for AD; the number of people with the disease doubles every 5 years beyond age 65. Three genes have been discovered that cause early onset (familial) AD. Other genetic mutations that cause excessive accumulation of amyloid protein are associated with age-related (sporadic) AD.

Alzheimer’s disease is a progressive, irreversible brain disorder. Alzheimer’s disease (AD) is the most common form of dementia among older people. Alzheimer’ destroys a person’s memory and ability to learn, reason, make judgments, communicate and carry out daily activities. Genetic factors are suspected, and dominant mutations in three different genes have been identified that account for a much smaller number of cases of familial, early-onset AD. People with dementia often have trouble thinking and speaking clearly, remembering recent events, and learning new things. Over time, it becomes hard for them to handle everyday activities and take care of themselves.  AD is part of an immune response that is attempting to contain the disease. The former may be more likely, since research indicates that anti-inflammatory drugs can prevent or retard AD development.

Alzheimer’s disease advances at widely different rates.  Family history is another risk factor of Alzheimer’s. Several risk factor genes may interact with each other and with non-genetic factors to cause the disease. Cardiovascular Risk Factors The same factors that increase the risk for heart disease and stroke, such as high blood pressure, may also increase the risk for late-onset AD. Most people with mild forgetfulness do not have AD. In the early stage of AD, people may have trouble remembering recent events, activities, or the names of familiar people or things. Oxidative damage refers to cell damage caused by excess free radicals, which are highly reactive chemicals. Free radicals are often formed as a by-product of metabolism, or chemical processes within the cell. Excess free radicals may cause substantial neuronal damage, contributing to AD development. Type 2 Diabetes. A link between AD and type 2 diabetes, the form of diabetes in which insulin levels are high. One theory is that too much insulin in the blood promotes inflammation and oxidative damage in the brain, both of which contribute to AD development.

Symptoms of AD include memory loss, language deterioration, impaired ability to mentally manipulate visual information, poor judgment, confusion, restlessness, and mood swings. Alzheimer’s disease may also include behavioral changes, such as outbursts of violence or excessive passivity in people who have no previous history of such behavior. In the later stages, deterioration of musculature and mobility, leading to bedfastness, inability to feed oneself, and incontinence, will be seen if death from some external cause (e.g. heart attack or pneumonia) does not intervene. Moderate -As the disease progresses to the middle stage, the patient might still be able to perform tasks independently, but may need assistance with more complicated activities. Severe — As the disease progresses from the middle to late stage, the patient will undoubtedly not be able to perform even the simplest of tasks on their own and will need constant supervision. They may even lose the ability to walk or eat without assistance. They might forget to eat and starve.

Treatment Alzheimer’s Disease Tips

1. Acetylcholinesterase (AChE)-inhibitors reduce the rate at which acetylcholine (ACh) is broken down and hence increase the concentration of ACh in the brain (combatting the loss of ACh caused by the death of the cholinergin neurons).

2. Ginkgo for the treatment of “cognitive impairment and dementia,” a Cochrane Review concludes that “there is promising evidence of improvement in cognition and function associated with Ginkgo According to this review the two randomized controlled studies that focused on Alzheimer’s patients both showed significant improvement in these areas.

3. Tramiprosate (3APS or Alzhemed) is a GAG-mimetic molecule that is believed to act by binding to soluble amyloid beta to prevent the accumulation of the toxic plaques.

4. R-flurbiprofen (MPC-7869) is a gamma secretase modulator sometimes called a selective amyloid beta 42 lowering agent. It is believed to reduce the production of the toxic amyloid beta in favor of shorter forms of the peptide.

5. Leuprolide has also been studied for Alzheimer’s. It is hypothesized to work by reducing leutenizing hormone levels which may be causing damage in the brain as one ages.

6. Antihistamine drug Dimebon has also recently been found to show beneficial effects against Alzheimer’s disease in preliminary trials

7. Vaccines or immunotherapy for Alzheimer’s, unlike typical vaccines, would be used to treat diagnosed patients rather than for disease prevention.

8. Proposed alternative treatments for Alzheimer’s include a range of herbal compounds and dietary supplements.

9. Cognitive and behavioral interventions and rehabilitation strategies may be used as an adjunct to pharmacologic treatmentFree Reprint Articles

10. DNA-based therapy is also  Treating Alzheimer’s Disease.

Article Tags:
Treating Alzheimer’s Disease, Treating Alzheimer’s, Alzheimer’s Disease, Amyloid Beta

Juliet Cohen writes articles for health care clinic and home remedies. She also writes articles on beauty tips.

Treating Alzheimer’s Disease

January 2, 2011
By

Treating Alzheimer’s Disease

Health Articles | July 17, 2007

Age is the most important risk factor for AD; the number of people with the disease doubles every 5 years beyond age 65. Three genes have been discovered that cause early onset (familial) AD. Other genetic mutations that cause excessive accumulation of amyloid protein are associated with age-related (sporadic) AD.

Alzheimer’s disease is a progressive, irreversible brain disorder. Alzheimer’s disease (AD) is the most common form of dementia among older people. Alzheimer’ destroys a person’s memory and ability to learn, reason, make judgments, communicate and carry out daily activities. Genetic factors are suspected, and dominant mutations in three different genes have been identified that account for a much smaller number of cases of familial, early-onset AD. People with dementia often have trouble thinking and speaking clearly, remembering recent events, and learning new things. Over time, it becomes hard for them to handle everyday activities and take care of themselves.  AD is part of an immune response that is attempting to contain the disease. The former may be more likely, since research indicates that anti-inflammatory drugs can prevent or retard AD development.

Alzheimer’s disease advances at widely different rates.  Family history is another risk factor of Alzheimer’s. Several risk factor genes may interact with each other and with non-genetic factors to cause the disease. Cardiovascular Risk Factors The same factors that increase the risk for heart disease and stroke, such as high blood pressure, may also increase the risk for late-onset AD. Most people with mild forgetfulness do not have AD. In the early stage of AD, people may have trouble remembering recent events, activities, or the names of familiar people or things. Oxidative damage refers to cell damage caused by excess free radicals, which are highly reactive chemicals. Free radicals are often formed as a by-product of metabolism, or chemical processes within the cell. Excess free radicals may cause substantial neuronal damage, contributing to AD development. Type 2 Diabetes. A link between AD and type 2 diabetes, the form of diabetes in which insulin levels are high. One theory is that too much insulin in the blood promotes inflammation and oxidative damage in the brain, both of which contribute to AD development.

Symptoms of AD include memory loss, language deterioration, impaired ability to mentally manipulate visual information, poor judgment, confusion, restlessness, and mood swings. Alzheimer’s disease may also include behavioral changes, such as outbursts of violence or excessive passivity in people who have no previous history of such behavior. In the later stages, deterioration of musculature and mobility, leading to bedfastness, inability to feed oneself, and incontinence, will be seen if death from some external cause (e.g. heart attack or pneumonia) does not intervene. Moderate -As the disease progresses to the middle stage, the patient might still be able to perform tasks independently, but may need assistance with more complicated activities. Severe — As the disease progresses from the middle to late stage, the patient will undoubtedly not be able to perform even the simplest of tasks on their own and will need constant supervision. They may even lose the ability to walk or eat without assistance. They might forget to eat and starve.

Treatment Alzheimer’s Disease Tips

1. Acetylcholinesterase (AChE)-inhibitors reduce the rate at which acetylcholine (ACh) is broken down and hence increase the concentration of ACh in the brain (combatting the loss of ACh caused by the death of the cholinergin neurons).

2. Ginkgo for the treatment of “cognitive impairment and dementia,” a Cochrane Review concludes that “there is promising evidence of improvement in cognition and function associated with Ginkgo According to this review the two randomized controlled studies that focused on Alzheimer’s patients both showed significant improvement in these areas.

3. Tramiprosate (3APS or Alzhemed) is a GAG-mimetic molecule that is believed to act by binding to soluble amyloid beta to prevent the accumulation of the toxic plaques.

4. R-flurbiprofen (MPC-7869) is a gamma secretase modulator sometimes called a selective amyloid beta 42 lowering agent. It is believed to reduce the production of the toxic amyloid beta in favor of shorter forms of the peptide.

5. Leuprolide has also been studied for Alzheimer’s. It is hypothesized to work by reducing leutenizing hormone levels which may be causing damage in the brain as one ages.

6. Antihistamine drug Dimebon has also recently been found to show beneficial effects against Alzheimer’s disease in preliminary trials

7. Vaccines or immunotherapy for Alzheimer’s, unlike typical vaccines, would be used to treat diagnosed patients rather than for disease prevention.

8. Proposed alternative treatments for Alzheimer’s include a range of herbal compounds and dietary supplements.

9. Cognitive and behavioral interventions and rehabilitation strategies may be used as an adjunct to pharmacologic treatment

10. DNA-based therapy is also  Treating Alzheimer’s Disease.

Article Tags:
Treating Alzheimer’s Disease, Treating Alzheimer’s, Alzheimer’s Disease, Amyloid Beta

Juliet Cohen writes articles for health care clinic and home remedies. She also writes articles on beauty tips.

Treating Alzheimer’s Disease

January 2, 2011
By

Treating Alzheimer’s Disease

Health Articles | July 17, 2007

Age is the most important risk factor for AD; the number of people with the disease doubles every 5 years beyond age 65. Three genes have been discovered that cause early onset (familial) AD. Other genetic mutations that cause excessive accumulation of amyloid protein are associated with age-related (sporadic) AD.

Alzheimer’s disease is a progressive, irreversible brain disorder. Alzheimer’s disease (AD) is the most common form of dementia among older people. Alzheimer’ destroys a person’s memory and ability to learn, reason, make judgments, communicate and carry out daily activities. Genetic factors are suspected, and dominant mutations in three different genes have been identified that account for a much smaller number of cases of familial, early-onset AD. People with dementia often have trouble thinking and speaking clearly, remembering recent events, and learning new things. Over time, it becomes hard for them to handle everyday activities and take care of themselves.  AD is part of an immune response that is attempting to contain the disease. The former may be more likely, since research indicates that anti-inflammatory drugs can prevent or retard AD development.

Alzheimer’s disease advances at widely different rates.  Family history is another risk factor of Alzheimer’s. Several risk factor genes may interact with each other and with non-genetic factors to cause the disease. Cardiovascular Risk Factors The same factors that increase the risk for heart disease and stroke, such as high blood pressure, may also increase the risk for late-onset AD. Most people with mild forgetfulness do not have AD. In the early stage of AD, people may have trouble remembering recent events, activities, or the names of familiar people or things. Oxidative damage refers to cell damage caused by excess free radicals, which are highly reactive chemicals. Free radicals are often formed as a by-product of metabolism, or chemical processes within the cell. Excess free radicals may cause substantial neuronal damage, contributing to AD development. Type 2 Diabetes. A link between AD and type 2 diabetes, the form of diabetes in which insulin levels are high. One theory is that too much insulin in the blood promotes inflammation and oxidative damage in the brain, both of which contribute to AD development.

Symptoms of AD include memory loss, language deterioration, impaired ability to mentally manipulate visual information, poor judgment, confusion, restlessness, and mood swings. Alzheimer’s disease may also include behavioral changes, such as outbursts of violence or excessive passivity in people who have no previous history of such behavior. In the later stages, deterioration of musculature and mobility, leading to bedfastness, inability to feed oneself, and incontinence, will be seen if death from some external cause (e.g. heart attack or pneumonia) does not intervene. Moderate -As the disease progresses to the middle stage, the patient might still be able to perform tasks independently, but may need assistance with more complicated activities. Severe — As the disease progresses from the middle to late stage, the patient will undoubtedly not be able to perform even the simplest of tasks on their own and will need constant supervision. They may even lose the ability to walk or eat without assistance. They might forget to eat and starve.

Treatment Alzheimer’s Disease Tips

1. Acetylcholinesterase (AChE)-inhibitors reduce the rate at which acetylcholine (ACh) is broken down and hence increase the concentration of ACh in the brain (combatting the loss of ACh caused by the death of the cholinergin neurons).

2. Ginkgo for the treatment of “cognitive impairment and dementia,” a Cochrane Review concludes that “there is promising evidence of improvement in cognition and function associated with Ginkgo According to this review the two randomized controlled studies that focused on Alzheimer’s patients both showed significant improvement in these areas.

3. Tramiprosate (3APS or Alzhemed) is a GAG-mimetic molecule that is believed to act by binding to soluble amyloid beta to prevent the accumulation of the toxic plaques.

4. R-flurbiprofen (MPC-7869) is a gamma secretase modulator sometimes called a selective amyloid beta 42 lowering agent. It is believed to reduce the production of the toxic amyloid beta in favor of shorter forms of the peptide.

5. Leuprolide has also been studied for Alzheimer’s. It is hypothesized to work by reducing leutenizing hormone levels which may be causing damage in the brain as one ages.

6. Antihistamine drug Dimebon has also recently been found to show beneficial effects against Alzheimer’s disease in preliminary trials

7. Vaccines or immunotherapy for Alzheimer’s, unlike typical vaccines, would be used to treat diagnosed patients rather than for disease prevention.

8. Proposed alternative treatments for Alzheimer’s include a range of herbal compounds and dietary supplements.

9. Cognitive and behavioral interventions and rehabilitation strategies may be used as an adjunct to pharmacologic treatmentFree Web Content

10. DNA-based therapy is also  Treating Alzheimer’s Disease.

Article Tags:
Treating Alzheimer’s Disease, Treating Alzheimer’s, Alzheimer’s Disease, Amyloid Beta

Juliet Cohen writes articles for health care clinic and home remedies. She also writes articles on beauty tips.

Signs And Symptoms Of Alzheimer’s Disease

December 31, 2010
By

One of the most common causes for dementia is Alzheimer’s disease. Alzheimer’s disease is the loss of intellectual and social abilities severe enough to interfere with daily functioning. The dementia is caused when healthy brain tissue degenerates. Memory and mental abilities steadily decline.

Alzheimer’s disease usually develops in people 65 or older. There is no cure for Alzheimer’s disease; however, researches are making progress. There are treatments available to improve the quality of life for some people with Alzheimer’s disease.

Signs and symptoms of Alzheimer’s disease include:

• Increasing and persistent forgetfulness: In the beginning of Alzheimer’s disease a person may experience periods of forgetfulness, especially of recent events or simple directions. This forgetfulness persists and worsens. People with Alzheimer’s disease routinely misplace things, often putting them in strange or “illogical” places. They frequently forget names, and may even eventually forget the names of family members and everyday objects.

• Difficulties with abstract thinking: People who suffer with Alzheimer’s disease may initially have trouble balancing their checkbook and may progress to trouble recognizing numbers.

• Loss of judgment: Common everyday problem solving such as knowing what to do if food on the stove is burning becomes increasingly difficult, eventually impossible. There is greater difficulty in doing things that require planning, decision making and judgment.

• Difficulty performing familiar tasks: Routine tasks that require sequential steps such as cooking become increasingly difficult as the disease progresses.

• Personality changes: Mood swings may occur. People with Alzheimer’s disease may begin to distrust others, become anxious or aggressive, show stubbornness and withdraw socially.

It is not a normal part of aging to forget the names of familiar people and objects, and may be a sign of Alzheimer’s disease. It is normal to forget the names of people whom you rarely see, but to forget the names of familiar people you see everyday is not normal.

Alzheimer’s disease is a progressive, degenerative brain disease that causes more than simple forgetfulness every now and then. Eventually, Alzheimer’s disease leads to irreversible mental impairment that destroys a person’s ability to remember, reason, learn and imagine.

The disease progresses differently from person to person. Once diagnosed with Alzheimer’s disease, eight years is the average length of time unto death. Some people, however, live more than a decade with the disease. Survival begins to decline three years after diagnosis.

Source: Mayo Foundation for Medical Education and Research

Disclaimer: *This article is not meant to diagnose, treat or cure any kind of a health problem. These statements have not been evaluated by the Food and Drug Administration. Always consult with your health care provider about any kind of a health problem and especially before beginning any kind of an exercise routine.

This article is FREE to publish with the resource box. Article written 3-2007.

Connie Limon, Trilogy Field Representative. Visit http://nutritionandhealthhub.com and sign up for a weekly nutrition and health tip. The article collection is available as FREE reprints for your newsletters, websites or blog. Visit http://www.healthylife27.com to purchase an array of superior quality, safe and effective products inspired by nature, informed by science and created to improve the health of people, pets and the planet.

Treating Alzheimer’s Disease

November 25, 2010
By

Treating Alzheimer’s Disease

Health Articles | July 17, 2007

Age is the most important risk factor for AD; the number of people with the disease doubles every 5 years beyond age 65. Three genes have been discovered that cause early onset (familial) AD. Other genetic mutations that cause excessive accumulation of amyloid protein are associated with age-related (sporadic) AD.

Alzheimer’s disease is a progressive, irreversible brain disorder. Alzheimer’s disease (AD) is the most common form of dementia among older people. Alzheimer’ destroys a person’s memory and ability to learn, reason, make judgments, communicate and carry out daily activities. Genetic factors are suspected, and dominant mutations in three different genes have been identified that account for a much smaller number of cases of familial, early-onset AD. People with dementia often have trouble thinking and speaking clearly, remembering recent events, and learning new things. Over time, it becomes hard for them to handle everyday activities and take care of themselves.  AD is part of an immune response that is attempting to contain the disease. The former may be more likely, since research indicates that anti-inflammatory drugs can prevent or retard AD development.

Alzheimer’s disease advances at widely different rates.  Family history is another risk factor of Alzheimer’s. Several risk factor genes may interact with each other and with non-genetic factors to cause the disease. Cardiovascular Risk Factors The same factors that increase the risk for heart disease and stroke, such as high blood pressure, may also increase the risk for late-onset AD. Most people with mild forgetfulness do not have AD. In the early stage of AD, people may have trouble remembering recent events, activities, or the names of familiar people or things. Oxidative damage refers to cell damage caused by excess free radicals, which are highly reactive chemicals. Free radicals are often formed as a by-product of metabolism, or chemical processes within the cell. Excess free radicals may cause substantial neuronal damage, contributing to AD development. Type 2 Diabetes. A link between AD and type 2 diabetes, the form of diabetes in which insulin levels are high. One theory is that too much insulin in the blood promotes inflammation and oxidative damage in the brain, both of which contribute to AD development.

Symptoms of AD include memory loss, language deterioration, impaired ability to mentally manipulate visual information, poor judgment, confusion, restlessness, and mood swings. Alzheimer’s disease may also include behavioral changes, such as outbursts of violence or excessive passivity in people who have no previous history of such behavior. In the later stages, deterioration of musculature and mobility, leading to bedfastness, inability to feed oneself, and incontinence, will be seen if death from some external cause (e.g. heart attack or pneumonia) does not intervene. Moderate -As the disease progresses to the middle stage, the patient might still be able to perform tasks independently, but may need assistance with more complicated activities. Severe — As the disease progresses from the middle to late stage, the patient will undoubtedly not be able to perform even the simplest of tasks on their own and will need constant supervision. They may even lose the ability to walk or eat without assistance. They might forget to eat and starve.

Treatment Alzheimer’s Disease Tips

1. Acetylcholinesterase (AChE)-inhibitors reduce the rate at which acetylcholine (ACh) is broken down and hence increase the concentration of ACh in the brain (combatting the loss of ACh caused by the death of the cholinergin neurons).

2. Ginkgo for the treatment of “cognitive impairment and dementia,” a Cochrane Review concludes that “there is promising evidence of improvement in cognition and function associated with Ginkgo According to this review the two randomized controlled studies that focused on Alzheimer’s patients both showed significant improvement in these areas.

3. Tramiprosate (3APS or Alzhemed) is a GAG-mimetic molecule that is believed to act by binding to soluble amyloid beta to prevent the accumulation of the toxic plaques.

4. R-flurbiprofen (MPC-7869) is a gamma secretase modulator sometimes called a selective amyloid beta 42 lowering agent. It is believed to reduce the production of the toxic amyloid beta in favor of shorter forms of the peptide.

5. Leuprolide has also been studied for Alzheimer’s. It is hypothesized to work by reducing leutenizing hormone levels which may be causing damage in the brain as one ages.

6. Antihistamine drug Dimebon has also recently been found to show beneficial effects against Alzheimer’s disease in preliminary trials

7. Vaccines or immunotherapy for Alzheimer’s, unlike typical vaccines, would be used to treat diagnosed patients rather than for disease prevention.

8. Proposed alternative treatments for Alzheimer’s include a range of herbal compounds and dietary supplements.

9. Cognitive and behavioral interventions and rehabilitation strategies may be used as an adjunct to pharmacologic treatmentArticle Search

10. DNA-based therapy is also  Treating Alzheimer’s Disease.

Article Tags:
Treating Alzheimer’s Disease, Treating Alzheimer’s, Alzheimer’s Disease, Amyloid Beta

Juliet Cohen writes articles for health care clinic and home remedies. She also writes articles on beauty tips.

Treating Alzheimer’s Disease

November 22, 2010
By

Treating Alzheimer’s Disease

Health Articles | July 17, 2007

Age is the most important risk factor for AD; the number of people with the disease doubles every 5 years beyond age 65. Three genes have been discovered that cause early onset (familial) AD. Other genetic mutations that cause excessive accumulation of amyloid protein are associated with age-related (sporadic) AD.

Alzheimer’s disease is a progressive, irreversible brain disorder. Alzheimer’s disease (AD) is the most common form of dementia among older people. Alzheimer’ destroys a person’s memory and ability to learn, reason, make judgments, communicate and carry out daily activities. Genetic factors are suspected, and dominant mutations in three different genes have been identified that account for a much smaller number of cases of familial, early-onset AD. People with dementia often have trouble thinking and speaking clearly, remembering recent events, and learning new things. Over time, it becomes hard for them to handle everyday activities and take care of themselves.  AD is part of an immune response that is attempting to contain the disease. The former may be more likely, since research indicates that anti-inflammatory drugs can prevent or retard AD development.

Alzheimer’s disease advances at widely different rates.  Family history is another risk factor of Alzheimer’s. Several risk factor genes may interact with each other and with non-genetic factors to cause the disease. Cardiovascular Risk Factors The same factors that increase the risk for heart disease and stroke, such as high blood pressure, may also increase the risk for late-onset AD. Most people with mild forgetfulness do not have AD. In the early stage of AD, people may have trouble remembering recent events, activities, or the names of familiar people or things. Oxidative damage refers to cell damage caused by excess free radicals, which are highly reactive chemicals. Free radicals are often formed as a by-product of metabolism, or chemical processes within the cell. Excess free radicals may cause substantial neuronal damage, contributing to AD development. Type 2 Diabetes. A link between AD and type 2 diabetes, the form of diabetes in which insulin levels are high. One theory is that too much insulin in the blood promotes inflammation and oxidative damage in the brain, both of which contribute to AD development.

Symptoms of AD include memory loss, language deterioration, impaired ability to mentally manipulate visual information, poor judgment, confusion, restlessness, and mood swings. Alzheimer’s disease may also include behavioral changes, such as outbursts of violence or excessive passivity in people who have no previous history of such behavior. In the later stages, deterioration of musculature and mobility, leading to bedfastness, inability to feed oneself, and incontinence, will be seen if death from some external cause (e.g. heart attack or pneumonia) does not intervene. Moderate -As the disease progresses to the middle stage, the patient might still be able to perform tasks independently, but may need assistance with more complicated activities. Severe — As the disease progresses from the middle to late stage, the patient will undoubtedly not be able to perform even the simplest of tasks on their own and will need constant supervision. They may even lose the ability to walk or eat without assistance. They might forget to eat and starve.

Treatment Alzheimer’s Disease Tips

1. Acetylcholinesterase (AChE)-inhibitors reduce the rate at which acetylcholine (ACh) is broken down and hence increase the concentration of ACh in the brain (combatting the loss of ACh caused by the death of the cholinergin neurons).

2. Ginkgo for the treatment of “cognitive impairment and dementia,” a Cochrane Review concludes that “there is promising evidence of improvement in cognition and function associated with Ginkgo According to this review the two randomized controlled studies that focused on Alzheimer’s patients both showed significant improvement in these areas.

3. Tramiprosate (3APS or Alzhemed) is a GAG-mimetic molecule that is believed to act by binding to soluble amyloid beta to prevent the accumulation of the toxic plaques.

4. R-flurbiprofen (MPC-7869) is a gamma secretase modulator sometimes called a selective amyloid beta 42 lowering agent. It is believed to reduce the production of the toxic amyloid beta in favor of shorter forms of the peptide.

5. Leuprolide has also been studied for Alzheimer’s. It is hypothesized to work by reducing leutenizing hormone levels which may be causing damage in the brain as one ages.

6. Antihistamine drug Dimebon has also recently been found to show beneficial effects against Alzheimer’s disease in preliminary trials

7. Vaccines or immunotherapy for Alzheimer’s, unlike typical vaccines, would be used to treat diagnosed patients rather than for disease prevention.

8. Proposed alternative treatments for Alzheimer’s include a range of herbal compounds and dietary supplements.

9. Cognitive and behavioral interventions and rehabilitation strategies may be used as an adjunct to pharmacologic treatmentBusiness Management Articles

10. DNA-based therapy is also  Treating Alzheimer’s Disease.

Article Tags:
Treating Alzheimer’s Disease, Treating Alzheimer’s, Alzheimer’s Disease, Amyloid Beta

Juliet Cohen writes articles for health care clinic and home remedies. She also writes articles on beauty tips.

Treating Alzheimer’s Disease

November 14, 2010
By

Treating Alzheimer’s Disease

Health Articles | July 17, 2007

Age is the most important risk factor for AD; the number of people with the disease doubles every 5 years beyond age 65. Three genes have been discovered that cause early onset (familial) AD. Other genetic mutations that cause excessive accumulation of amyloid protein are associated with age-related (sporadic) AD.

Alzheimer’s disease is a progressive, irreversible brain disorder. Alzheimer’s disease (AD) is the most common form of dementia among older people. Alzheimer’ destroys a person’s memory and ability to learn, reason, make judgments, communicate and carry out daily activities. Genetic factors are suspected, and dominant mutations in three different genes have been identified that account for a much smaller number of cases of familial, early-onset AD. People with dementia often have trouble thinking and speaking clearly, remembering recent events, and learning new things. Over time, it becomes hard for them to handle everyday activities and take care of themselves.  AD is part of an immune response that is attempting to contain the disease. The former may be more likely, since research indicates that anti-inflammatory drugs can prevent or retard AD development.

Alzheimer’s disease advances at widely different rates.  Family history is another risk factor of Alzheimer’s. Several risk factor genes may interact with each other and with non-genetic factors to cause the disease. Cardiovascular Risk Factors The same factors that increase the risk for heart disease and stroke, such as high blood pressure, may also increase the risk for late-onset AD. Most people with mild forgetfulness do not have AD. In the early stage of AD, people may have trouble remembering recent events, activities, or the names of familiar people or things. Oxidative damage refers to cell damage caused by excess free radicals, which are highly reactive chemicals. Free radicals are often formed as a by-product of metabolism, or chemical processes within the cell. Excess free radicals may cause substantial neuronal damage, contributing to AD development. Type 2 Diabetes. A link between AD and type 2 diabetes, the form of diabetes in which insulin levels are high. One theory is that too much insulin in the blood promotes inflammation and oxidative damage in the brain, both of which contribute to AD development.

Symptoms of AD include memory loss, language deterioration, impaired ability to mentally manipulate visual information, poor judgment, confusion, restlessness, and mood swings. Alzheimer’s disease may also include behavioral changes, such as outbursts of violence or excessive passivity in people who have no previous history of such behavior. In the later stages, deterioration of musculature and mobility, leading to bedfastness, inability to feed oneself, and incontinence, will be seen if death from some external cause (e.g. heart attack or pneumonia) does not intervene. Moderate -As the disease progresses to the middle stage, the patient might still be able to perform tasks independently, but may need assistance with more complicated activities. Severe — As the disease progresses from the middle to late stage, the patient will undoubtedly not be able to perform even the simplest of tasks on their own and will need constant supervision. They may even lose the ability to walk or eat without assistance. They might forget to eat and starve.

Treatment Alzheimer’s Disease Tips

1. Acetylcholinesterase (AChE)-inhibitors reduce the rate at which acetylcholine (ACh) is broken down and hence increase the concentration of ACh in the brain (combatting the loss of ACh caused by the death of the cholinergin neurons).

2. Ginkgo for the treatment of “cognitive impairment and dementia,” a Cochrane Review concludes that “there is promising evidence of improvement in cognition and function associated with Ginkgo According to this review the two randomized controlled studies that focused on Alzheimer’s patients both showed significant improvement in these areas.

3. Tramiprosate (3APS or Alzhemed) is a GAG-mimetic molecule that is believed to act by binding to soluble amyloid beta to prevent the accumulation of the toxic plaques.

4. R-flurbiprofen (MPC-7869) is a gamma secretase modulator sometimes called a selective amyloid beta 42 lowering agent. It is believed to reduce the production of the toxic amyloid beta in favor of shorter forms of the peptide.

5. Leuprolide has also been studied for Alzheimer’s. It is hypothesized to work by reducing leutenizing hormone levels which may be causing damage in the brain as one ages.

6. Antihistamine drug Dimebon has also recently been found to show beneficial effects against Alzheimer’s disease in preliminary trials

7. Vaccines or immunotherapy for Alzheimer’s, unlike typical vaccines, would be used to treat diagnosed patients rather than for disease prevention.

8. Proposed alternative treatments for Alzheimer’s include a range of herbal compounds and dietary supplements.

9. Cognitive and behavioral interventions and rehabilitation strategies may be used as an adjunct to pharmacologic treatmentBusiness Management Articles

10. DNA-based therapy is also  Treating Alzheimer’s Disease.

Article Tags:
Treating Alzheimer’s Disease, Treating Alzheimer’s, Alzheimer’s Disease, Amyloid Beta

Juliet Cohen writes articles for health care clinic and home remedies. She also writes articles on beauty tips.

Treating Alzheimer’s Disease

October 6, 2010
By

Treating Alzheimer’s Disease

Health Articles | July 17, 2007

Age is the most important risk factor for AD; the number of people with the disease doubles every 5 years beyond age 65. Three genes have been discovered that cause early onset (familial) AD. Other genetic mutations that cause excessive accumulation of amyloid protein are associated with age-related (sporadic) AD.

Alzheimer’s disease is a progressive, irreversible brain disorder. Alzheimer’s disease (AD) is the most common form of dementia among older people. Alzheimer’ destroys a person’s memory and ability to learn, reason, make judgments, communicate and carry out daily activities. Genetic factors are suspected, and dominant mutations in three different genes have been identified that account for a much smaller number of cases of familial, early-onset AD. People with dementia often have trouble thinking and speaking clearly, remembering recent events, and learning new things. Over time, it becomes hard for them to handle everyday activities and take care of themselves.  AD is part of an immune response that is attempting to contain the disease. The former may be more likely, since research indicates that anti-inflammatory drugs can prevent or retard AD development.

Alzheimer’s disease advances at widely different rates.  Family history is another risk factor of Alzheimer’s. Several risk factor genes may interact with each other and with non-genetic factors to cause the disease. Cardiovascular Risk Factors The same factors that increase the risk for heart disease and stroke, such as high blood pressure, may also increase the risk for late-onset AD. Most people with mild forgetfulness do not have AD. In the early stage of AD, people may have trouble remembering recent events, activities, or the names of familiar people or things. Oxidative damage refers to cell damage caused by excess free radicals, which are highly reactive chemicals. Free radicals are often formed as a by-product of metabolism, or chemical processes within the cell. Excess free radicals may cause substantial neuronal damage, contributing to AD development. Type 2 Diabetes. A link between AD and type 2 diabetes, the form of diabetes in which insulin levels are high. One theory is that too much insulin in the blood promotes inflammation and oxidative damage in the brain, both of which contribute to AD development.

Symptoms of AD include memory loss, language deterioration, impaired ability to mentally manipulate visual information, poor judgment, confusion, restlessness, and mood swings. Alzheimer’s disease may also include behavioral changes, such as outbursts of violence or excessive passivity in people who have no previous history of such behavior. In the later stages, deterioration of musculature and mobility, leading to bedfastness, inability to feed oneself, and incontinence, will be seen if death from some external cause (e.g. heart attack or pneumonia) does not intervene. Moderate -As the disease progresses to the middle stage, the patient might still be able to perform tasks independently, but may need assistance with more complicated activities. Severe — As the disease progresses from the middle to late stage, the patient will undoubtedly not be able to perform even the simplest of tasks on their own and will need constant supervision. They may even lose the ability to walk or eat without assistance. They might forget to eat and starve.

Treatment Alzheimer’s Disease Tips

1. Acetylcholinesterase (AChE)-inhibitors reduce the rate at which acetylcholine (ACh) is broken down and hence increase the concentration of ACh in the brain (combatting the loss of ACh caused by the death of the cholinergin neurons).

2. Ginkgo for the treatment of “cognitive impairment and dementia,” a Cochrane Review concludes that “there is promising evidence of improvement in cognition and function associated with Ginkgo According to this review the two randomized controlled studies that focused on Alzheimer’s patients both showed significant improvement in these areas.

3. Tramiprosate (3APS or Alzhemed) is a GAG-mimetic molecule that is believed to act by binding to soluble amyloid beta to prevent the accumulation of the toxic plaques.

4. R-flurbiprofen (MPC-7869) is a gamma secretase modulator sometimes called a selective amyloid beta 42 lowering agent. It is believed to reduce the production of the toxic amyloid beta in favor of shorter forms of the peptide.

5. Leuprolide has also been studied for Alzheimer’s. It is hypothesized to work by reducing leutenizing hormone levels which may be causing damage in the brain as one ages.

6. Antihistamine drug Dimebon has also recently been found to show beneficial effects against Alzheimer’s disease in preliminary trials

7. Vaccines or immunotherapy for Alzheimer’s, unlike typical vaccines, would be used to treat diagnosed patients rather than for disease prevention.

8. Proposed alternative treatments for Alzheimer’s include a range of herbal compounds and dietary supplements.

9. Cognitive and behavioral interventions and rehabilitation strategies may be used as an adjunct to pharmacologic treatmentScience Articles

10. DNA-based therapy is also  Treating Alzheimer’s Disease.

Article Tags:
Treating Alzheimer’s Disease, Treating Alzheimer’s, Alzheimer’s Disease, Amyloid Beta

Juliet Cohen writes articles for health care clinic and home remedies. She also writes articles on beauty tips.

Alzheimer’s Disease in the Elderly – What Can be Done ?

May 8, 2010
By

Alzheimer’s disease, Alzheimer’s or as some refer to this malady with the sound alike, similar sounding term “Old Timers” affects many people in their later years. Whether it was around all the time, and the diagnosis or label was not readily available or testable or now, or whether it is just a catch phrase by health care providers to provide a label for the family no one can really ascertain or say for sure. One major point can be made however when it comes to Alzheimer’s disease, its diagnosis and progress is that memory loss by itself, is not part and not necessarily part of healthy aging. Alzheimer’s disease is something entirely different than ordinary standard aging as people grow older. Not all the elderly or will most people as they age “just get Alzheimer Disease”. It only happens to some as they age – it is not an eventuality that all the elderly and indeed ourselves will face with certainty in our later years.

The one catch phrase that covers the memory loss that occurs in people as they age – in the elderly component of our populations is the medical term “dementia”. Dementia is the larger catch phrase – the larger pool of patients who suffer from a variety and any number of illnesses that can result in memory loss. Dementia is not one disease – but a whole rainbow – a spectrum of a number of diseases of illnesses. Among the other illnesses that can be included in the larger overall group of dementia include – dementia as a result of strokes ( vascular dementia) , dementia as a result of physical problems in the brain ( fronto-temporal dementia), the group of brain disorders that most commonly serve as the model for mad cow disease “ Creutzfeld-Jakob disease”, among others. It can be said that Alzheimer’s disease is only one illness in this whole mix of illnesses that can cause memory loss. All patients who are said to have dementia may have memory loss – it may be minor, it may be more major, it may progress with time. On the other side of the coin – patients who do have Alzheimer’s disease will be said it have dementia.

What makes Alzheimer’s disease different and so readily identifiable than the others is that actual changes can be seen inside the brains of people who suffer from this illness and malady. Inside the brains of Alzheimer’s patient’s accumulations known specifically as “plaque” and “plaques” build up and start to actually choke off what were once very healthy brain cells. It can be said that in Alzheimer’s disease that the brain are actually choked off and killed by the blockage afforded within the brain itself by these plaques and plaque compounds. With time the brains of Alzheimer’s patients can be actually said to wither away. What results from the occurrence and growth of these plaque and areas of plaques are both plaques and areas of tangle in the brain?

Alzheimer’s disease is a progressive, accumulative degenerative disease. Alzheimer’s disease seldom gets better, as time goes on the plaque and areas of plaques and tangles do their damage. The damages to the brain and specifically to memory are accumulative – that is they grow and increase with time. With an Alzheimer’s disease patent it is unlikely that they will recover or “get better”. Rather the hope with medications and the especially the newer Alzheimer’s Disease treatment medications is that the progress and advance of Alzheimer’s will be slowed down and reduced greatly in patients.

Powered by Yahoo! Answers

Local Events, Concerts, Tickets
Events by Eventful